These fascicles are disrupted in many neurodegenerative diseases and hence, the understanding of fascicle formation could give clues on the prevention of a number of diseases.
A new collaborative project has been launched to engage students from five universities in the US, the UK and India to help discover new drugs for neglected diseases.
Netherlands-based biotechnology company argenx and Broteio Pharma, a joint venture between Prothix and Bioceros, have agreed to partner for the development of a therapeutic antibody for severe autoimmune diseases.